Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis

It has been shown that the loss of function of the BRCA1, BRCA2, and PALB2 genes due to a number of hereditary mutations or chromosomal aberrations can affect the effectiveness of chemotherapy treatment and disease prognosis in patients with various types of cancer, and in particular in breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsyganov, Matvey M., Sorokovikova, Sofia S., Lutzkaya, Elizaveta A., Ibragimova, Marina K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454606/
https://www.ncbi.nlm.nih.gov/pubmed/37628606
http://dx.doi.org/10.3390/genes14081554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454606/
https://www.ncbi.nlm.nih.gov/pubmed/37628606
http://dx.doi.org/10.3390/genes14081554

Ejemplares similares